TITUSVILLE, Fla., Jan. 23, 2018 -- The Apple Rush Company, Inc. (OTCPINK:APRU) (the “Company”) is pleased to announce to its shareholders and partners that it has engaged Law Office of Clifford J. Hunt, P.A. and Clifford J. Hunt, Esquire of St. Petersburg, Florida, as its new, outside corporate counsel to provide securities and corporate representation services for the Company. “Mr. Hunt has over 31 years’ experience in the practice area of securities and corporate governance law and we are excited to be working with him and his law firm,” said Tony Torgerud, CEO. Mr. Torgerud further stated that “Mr. Hunt will be assisting us with, among other things, our various projects to implement our corporate acquisition strategy and to bring our periodic disclosure filings current with OTC Markets Group. He has substantial experience in securities and corporate litigation matters from early in his legal career and in the last 20 years has provided legal services in mergers and acquisitions, securities offerings, including private placements and filing of registration statements with the United States Securities and Exchange Commission (“SEC”), as well as assisting public companies with their periodic filings with the SEC. We believe that Mr. Hunt’s vast experience in securities and corporate governance matters will be of great benefit and assistance to us as we move forward with our business plan and growing our Company.”
About Apple Rush Co, Inc. (APRU)
The Apple Rush Company, Inc. through its subsidiary APRU, LLC, Alternative PRoducts Unlimited is a manufacturer of specialty supplements including Anhydrous Hemp Oil, Kratom, Kava, and other active ingredients. The supplement format is its proprietary soft cold processed chew. The company markets its products through private label, white label, and through distributors in the United States and internationally. The company was founded in 1998 and is now based in Titusville, FL. www.aprullc.com.
Investor Relations Contact
Tony Torgerud
714-940-0155


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Instagram Outage Disrupts Thousands of U.S. Users
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



